182 CO Type | Company | Nationality | Region ==========+==============+==============+============ Originator|Glaxo Wellcome|United Kingdom| ----------+--------------+--------------+------------ Licensee |AstraZeneca |United Kingdom|Worldwide ----------+--------------+--------------+------------ Other |Cephalon |United States |UK ----------+--------------+--------------+------------ Assignee |Wellcome | | DRUGUPDATES Record Monitoring Drug Developments